6505--Sodium Bicarbonate Injection Vial Restricted to Made in America

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC PHARMACEUTICALS (36E797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36E79726R0041

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
This presolicitation notice announces the forthcoming release of Request for Proposal (RFP) 36E79726R0041 by the Department of Veterans Affairs (VA) Enterprise Procurement Office. The procurement seeks to establish a firm-fixed requirements-type contract for the supply of Sodium Bicarbonate Injection Vials, specifically restricted to products manufactured in the United States in accordance with FAR 6.103-3, which pertains to industrial mobilization and expert services. This restriction underscores the government’s commitment to sourcing critical pharmaceutical products domestically, ensuring supply chain security and compliance with “Made in America” requirements. The scope of this procurement is broad, encompassing the needs of multiple federal healthcare entities. The contract will support the VA—including its Consolidated Mail Order Pharmacies (CMOPs) and State Veterans Homes (SVH) under Option 2—as well as the Department of Defense (DoD) and its Tricare Mail Order Pharmacies (TMOPs), the Bureau of Prisons (BOP), the Indian Health Service (IHS), and the Federal Health Care Center (FHCC). The awarded contractor will be responsible for providing an uninterrupted supply of sodium bicarbonate for injection, with distribution facilitated through the VA’s and DoD’s respective Pharmaceutical Prime Vendor Programs. The primary requirement is for Sodium Bicarbonate 84mg/mL Injection, supplied in 50mL vials. The estimated annual usage is 65,587 bottles. Offerors must ensure that their product is labeled with a unique National Drug Code (NDC) specific to the offeror, and this label must be the only one affixed to the product. The VA reserves the right to affix its own labels securely on top of the contractor’s label, but contractors are prohibited from covering another manufacturer’s label with their own. Glass bottles are acceptable, and all packaging must be compatible with automated dispensing units such as Baxter ATC Canisters and Opti-fill systems, ensuring seamless integration into federal pharmacy operations. The contract is anticipated to have a base period of one year, with four additional pre-priced one-year option periods, providing a potential total contract duration of five years. This structure is designed to ensure long-term continuity of supply while allowing for periodic review and adjustment of contract terms. The procurement is classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), with Product Service Code 6505 (Drugs and Biologicals). The contracting entity is NAC Pharmaceuticals (36E797), a federal office within the Department of Veterans Affairs. The primary point of contact for this opportunity is Teresa Hussain, who can be reached at [email protected] or by phone at 708-786-5852. The solicitation will be issued electronically in accordance with FAR Part 12 (Acquisition of Commercial Items) on or about October 21, 2026, with a tentative closing date of November 18, 2026. All documents and future amendments will be available exclusively through SAM.gov; no paper copies will be provided. Interested offerors are encouraged to monitor the SAM.gov listing for updates and to submit any questions directly to the contracting officer. This opportunity is well-suited for domestic pharmaceutical manufacturers with the capability to produce and supply injectable sodium bicarbonate in compliance with federal labeling and packaging requirements, and who can ensure reliable, large-scale distribution to multiple federal healthcare systems. The long-term nature of the contract and the emphasis on uninterrupted supply make this a significant opportunity for qualified suppliers committed to supporting federal healthcare delivery.